Literature DB >> 20729301

Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review.

Julian H Barth1, Beryl M Jackson, Amanda J Farrin, Maria Efthymiou, Gillian Worthy, Joanne Copeland, Kristian M Bailey, Simon P R Romaine, Anthony J Balmforth, Terry McCormack, Andrew Whitehead, Marcus D Flather, Jane Nixon, Alistair S Hall.   

Abstract

BACKGROUND: It has long been an accepted belief that serum cholesterol significantly falls after myocardial infarction and that a return to pre-event levels takes approximately 3 months. The magnitude and clinical significance of this fall has recently been challenged.
METHODS: In the Secondary Prevention of Acute Coronary Events-Reduction Of Cholesterol to Key European Targets (SPACE ROCKET) trial, we measured serum lipids of individuals on day 1 and between days 2 and 4 after acute myocardial infarction (AMI). Second, we performed a thorough literature review and compared all studies reporting data on absolute changes in lipids immediately after AMI, using weighted means.
RESULTS: Of 1263 SPACE ROCKET participants, 128 had paired lipid measurements where both samples had been measured using identical methods at baseline and on days 2-4 after AMI. The mean lowering in total cholesterol between day 1 and day 2-4 was 0.71 mmol/L (95% CI 0.58-0.84; P < 0.0001) and in triglycerides was 0.10 mmol/L (-0.14-0.33; P = 0.405). A total of 25 papers showing absolute lipid changes post-AMI were identified. The combined data demonstrated a mean fall in total cholesterol of 9% to 11% from baseline over days 3-14 post-AMI, whereas for triglycerides, there was a rise of 18% from baseline to between day 9 and 12 weeks.
CONCLUSIONS: After a secondary analysis of SPACE ROCKET data and a comparison of previously published data, we report a 10% fall in total cholesterol after AMI-a difference that is of high clinical significance. Consequently, measurement of serum lipids in patients with AMI should be performed within the first hours after presentation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729301     DOI: 10.1373/clinchem.2010.145631

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Predictive and protective role of high-density lipoprotein cholesterol in acute myocardial infarction.

Authors:  Jin Sup Park; Kwang Soo Cha; Hye Won Lee; Jun-Hyok Oh; Jung Hyun Choi; Han Cheol Lee; Taek Jong Hong; Myung Ho Jeong; Shung Chull Chae; Young Jo Kim
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

2.  Lack of association between low density lipoprotein particle size and on-treatment platelet reactivity in patients with coronary artery disease.

Authors:  Do-Yoon Kang; Han-Mo Yang; Kyung Woo Park; So-Ryoung Lee; Min-Ho Lee; Dong-Won Lee; Hae-Young Lee; Hyun-Jae Kang; Bon-Kwon Koo; In-Ho Chae; Dong-Ju Choi; Hyo-Soo Kim; Cheol-Ho Kim
Journal:  Korean Circ J       Date:  2012-08-31       Impact factor: 3.243

3.  Prognostic value of low and moderately elevated C-reactive protein in acute coronary syndrome: a 2-year follow-up study.

Authors:  Ajvor Lukin; Katarina Novak; Stojan Polić; Livia Puljak
Journal:  Med Sci Monit       Date:  2013-09-20

4.  Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.

Authors:  Marie Skov Kristensen; Anders Green; Mads Nybo; Simone Møller Hede; Kristian Handberg Mikkelsen; Gunnar Gislason; Mogens Lytken Larsen; Annette Kjær Ersbøll
Journal:  BMC Cardiovasc Disord       Date:  2020-07-13       Impact factor: 2.298

5.  Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients.

Authors:  Mathias J Gerl; Winchil L C Vaz; Neuza Domingues; Christian Klose; Michal A Surma; Júlio L Sampaio; Manuel S Almeida; Gustavo Rodrigues; Pedro Araújo-Gonçalves; Jorge Ferreira; Claudia Borbinha; João Pedro Marto; Miguel Viana-Baptista; Kai Simons; Otilia V Vieira
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

6.  Association between plasma lipid levels during acute coronary syndrome and long-term malignancy risk. The ABC-4* study on heart disease.

Authors:  Giuseppe Berton; Rocco Cordiano; Fiorella Cavuto; Francesco Bagato; Heba Talat Mahmoud; Mattia Pasquinucci
Journal:  BMC Cardiovasc Disord       Date:  2019-05-20       Impact factor: 2.298

7.  Low G0S2 gene expression levels in peripheral blood may be a genetic marker of acute myocardial infarction in patients with stable coronary atherosclerotic disease: A retrospective clinical study.

Authors:  Xue Wang; Heyu Meng; Jianjun Ruan; Weiwei Chen; Fanbo Meng
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

8.  Association of Low Expression of NUMB in Peripheral Blood with Acute Myocardial Infarction.

Authors:  Heyu Meng; Lihong Li; Jianjun Ruan; Yanqiu Chen; Zhaohan Yan; Jinsha Liu; Xiangdong Li; Cuiying Mao; Ping Yang
Journal:  Cardiol Res Pract       Date:  2022-04-26       Impact factor: 1.990

9.  Plasma Quantitative Lipid Profiles: Identification of CarnitineC18:1-OH, CarnitineC18:2-OH and FFA (20:1) as Novel Biomarkers for Pre-warning and Prognosis in Acute Myocardial Infarction.

Authors:  Jun Liu; Liangqiu Tang; Qiqi Lu; Yi Yu; Qiu-Gui Xu; Shanqiang Zhang; Yun-Xian Chen; Wen-Jie Dai; Ji-Cheng Li
Journal:  Front Cardiovasc Med       Date:  2022-04-11

10.  Role of insulin-like growth factor 1 in stent thrombosis under effective dual antiplatelet therapy.

Authors:  Ahmet Arif Yalcin; Mustafa Topuz; Ismail Biyik; Ibrahim Faruk Akturk; Omer Celik; Nilgun Isıksacan; Burce Yalcın; Ali Birant; Fatih Uzun
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-11-17       Impact factor: 1.426

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.